tetano
Editor, Senior Moderator
PLoS One
. 2020 Nov 12;15(11):e0242182.
doi: 10.1371/journal.pone.0242182. eCollection 2020.
Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients
Matthew T Oetjens[SUP] 1 [/SUP], Jonathan Z Luo[SUP] 1 [/SUP], Alexander Chang[SUP] 1 [/SUP], Joseph B Leader[SUP] 1 [/SUP], Dustin N Hartzel[SUP] 1 [/SUP], Bryn S Moore[SUP] 1 [/SUP], Natasha T Strande[SUP] 1 [/SUP], H Lester Kirchner[SUP] 1 [/SUP], David H Ledbetter[SUP] 1 [/SUP], Anne E Justice[SUP] 1 [/SUP], David J Carey[SUP] 1 [/SUP], Tooraj Mirshahi[SUP] 1 [/SUP]
Affiliations
Abstract
Background: Empirical data on conditions that increase risk of coronavirus disease 2019 (COVID-19) progression are needed to identify high risk individuals. We performed a comprehensive quantitative assessment of pre-existing clinical phenotypes associated with COVID-19-related hospitalization.
Methods: Phenome-wide association study (PheWAS) of SARS-CoV-2-positive patients from an integrated health system (Geisinger) with system-level outpatient/inpatient COVID-19 testing capacity and retrospective electronic health record (EHR) data to assess pre-COVID-19 pandemic clinical phenotypes associated with hospital admission (hospitalization).
Results: Of 12,971 individuals tested for SARS-CoV-2 with sufficient pre-COVID-19 pandemic EHR data at Geisinger, 1604 were SARS-CoV-2 positive and 354 required hospitalization. We identified 21 clinical phenotypes in 5 disease categories meeting phenome-wide significance (P<1.60x10-4), including: six kidney phenotypes, e.g. end stage renal disease or stage 5 CKD (OR = 11.07, p = 1.96x10-8), six cardiovascular phenotypes, e.g. congestive heart failure (OR = 3.8, p = 3.24x10-5), five respiratory phenotypes, e.g. chronic airway obstruction (OR = 2.54, p = 3.71x10-5), and three metabolic phenotypes, e.g. type 2 diabetes (OR = 1.80, p = 7.51x10-5). Additional analyses defining CKD based on estimated glomerular filtration rate, confirmed high risk of hospitalization associated with pre-existing stage 4 CKD (OR 2.90, 95% CI: 1.47, 5.74), stage 5 CKD/dialysis (OR 8.83, 95% CI: 2.76, 28.27), and kidney transplant (OR 14.98, 95% CI: 2.77, 80.8) but not stage 3 CKD (OR 1.03, 95% CI: 0.71, 1.48).
Conclusions: This study provides quantitative estimates of the contribution of pre-existing clinical phenotypes to COVID-19 hospitalization and highlights kidney disorders as the strongest factors associated with hospitalization in an integrated US healthcare system.
. 2020 Nov 12;15(11):e0242182.
doi: 10.1371/journal.pone.0242182. eCollection 2020.
Electronic health record analysis identifies kidney disease as the leading risk factor for hospitalization in confirmed COVID-19 patients
Matthew T Oetjens[SUP] 1 [/SUP], Jonathan Z Luo[SUP] 1 [/SUP], Alexander Chang[SUP] 1 [/SUP], Joseph B Leader[SUP] 1 [/SUP], Dustin N Hartzel[SUP] 1 [/SUP], Bryn S Moore[SUP] 1 [/SUP], Natasha T Strande[SUP] 1 [/SUP], H Lester Kirchner[SUP] 1 [/SUP], David H Ledbetter[SUP] 1 [/SUP], Anne E Justice[SUP] 1 [/SUP], David J Carey[SUP] 1 [/SUP], Tooraj Mirshahi[SUP] 1 [/SUP]
Affiliations
- PMID: 33180868
- DOI: 10.1371/journal.pone.0242182
Abstract
Background: Empirical data on conditions that increase risk of coronavirus disease 2019 (COVID-19) progression are needed to identify high risk individuals. We performed a comprehensive quantitative assessment of pre-existing clinical phenotypes associated with COVID-19-related hospitalization.
Methods: Phenome-wide association study (PheWAS) of SARS-CoV-2-positive patients from an integrated health system (Geisinger) with system-level outpatient/inpatient COVID-19 testing capacity and retrospective electronic health record (EHR) data to assess pre-COVID-19 pandemic clinical phenotypes associated with hospital admission (hospitalization).
Results: Of 12,971 individuals tested for SARS-CoV-2 with sufficient pre-COVID-19 pandemic EHR data at Geisinger, 1604 were SARS-CoV-2 positive and 354 required hospitalization. We identified 21 clinical phenotypes in 5 disease categories meeting phenome-wide significance (P<1.60x10-4), including: six kidney phenotypes, e.g. end stage renal disease or stage 5 CKD (OR = 11.07, p = 1.96x10-8), six cardiovascular phenotypes, e.g. congestive heart failure (OR = 3.8, p = 3.24x10-5), five respiratory phenotypes, e.g. chronic airway obstruction (OR = 2.54, p = 3.71x10-5), and three metabolic phenotypes, e.g. type 2 diabetes (OR = 1.80, p = 7.51x10-5). Additional analyses defining CKD based on estimated glomerular filtration rate, confirmed high risk of hospitalization associated with pre-existing stage 4 CKD (OR 2.90, 95% CI: 1.47, 5.74), stage 5 CKD/dialysis (OR 8.83, 95% CI: 2.76, 28.27), and kidney transplant (OR 14.98, 95% CI: 2.77, 80.8) but not stage 3 CKD (OR 1.03, 95% CI: 0.71, 1.48).
Conclusions: This study provides quantitative estimates of the contribution of pre-existing clinical phenotypes to COVID-19 hospitalization and highlights kidney disorders as the strongest factors associated with hospitalization in an integrated US healthcare system.